Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | Breast and ovarian cancer genetic risk: MAGENTA

Elizabeth Swisher, MD, Seattle Cancer Care Alliance, University of Washington Medical Center, Seattle, WA, talks to us about the MAGENTA study (NCT02993068) which evaluated pre- and post-test genetic counseling during online testing for breast and ovarian cancer genetic risk. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).